Showing 1561-1570 of 3305 results for "".
Completing the Picture: How Skincare and Device Based Treatments are Reshaping Facial Aesthetics
https://practicaldermatology.com/topics/general-topics/completing-the-picture-how-skincare-and-device-based-treatments-are-reshaping-facial-aesthetics/21229/Histiocytoses: A Review of the Most Recent Classification System
https://practicaldermatology.com/topics/skin-cancer-photoprotection/histiocytoses-a-review-of-the-most-recent-classification-system/20503/A look at the proposed new classification system, grouping the histiocytoses into five categories, with tabular summaries for differential diagnosis.Managing Pruritus in Geriatric Patients
https://practicaldermatology.com/topics/practice-management/managing-pruritus-in-geriatric-patients/21146/Treatment tips and considerations for this patient population.Politicizing Certification
https://practicaldermatology.com/topics/practice-management/politicizing-certification/21092/Drug Companies, Insurance Companies, Pharmacists, the Government, Doctors and…Oh, Patients!
https://practicaldermatology.com/topics/practice-management/drug-companies-insurance-companies-pharmacists-the-government-doctors-andoh-patients/21063/Lashing Out: A New Direction in Lash Treatment
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/lashing-out-a-new-direction-in-lash-treatment/20743/New eyelash ptosis treatment means no more lash curlers.Pre-Treating Resectable Melanomas with PD-1 Inhibitors: An Emerging Strategy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pre-treating-resectable-melanomas-with-pd-1-inhibitors-an-emerging-strategy/20489/Pre-treatment with anti-PD1 agents may improve outcomes for some patients and provide prognostic clues.Histopathologic Assessment of Atypical Pigmented Lesions: Financial and Diagnostic Considerations
https://practicaldermatology.com/topics/skin-cancer-photoprotection/histopathologic-assessment-of-atypical-pigmented-lesions-financial-and-diagnostic-considerations/21335/Taking prospective deeper sections may prove more cost-efficient in the long-term.The American Academy of Dermatology Meeting in an Age of Contraction
https://practicaldermatology.com/topics/general-topics/the-american-academy-of-dermatology-meeting-in-an-age-of-contraction/21386/A New Era in Hidradenitis Suppurativa Care
https://practicaldermatology.com/topics/rare-disease/a-new-era-in-hidradenitis-suppurativa-care/56428/Remarkable innovation is happening in HS. Ultimately, it comes down to this: we are now able to provide patients with a level of care that was not previously possible because so many new therapies are being unlocked.